Berkeley, CA, United States of America

Sarah B Noonberg

This inventor holds 1 USPTO granted patent. Top assignee: University of California. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sarah B Noonberg. Retrieved from https://idiyas.com/inventor/sarah-b-noonberg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 252(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Sarah B Noonberg

Introduction

Sarah B Noonberg is a prominent inventor based in Berkeley, California. She has made significant contributions to the field of biotechnology, particularly in the development of methods for delivering oligonucleotides. Her work has the potential to impact various therapeutic applications.

Latest Patents

Sarah B Noonberg holds 1 patent for her invention titled "In vivo oligonucleotide generator, and methods of testing the binding." This invention encompasses improved methods and materials for delivering antisense, triplex, and ribozyme oligonucleotides intracellularly. It also includes RNA polymerase III-based constructs known as 'oligonucleotide generators' to facilitate the delivery of oligonucleotides. Additionally, her patent covers methods for screening oligonucleotide sequences that are candidates for triplex formation.

Career Highlights

Noonberg is affiliated with the University of California, where she continues to advance her research and innovation in the field. Her work is characterized by a commitment to improving biotechnological methods and enhancing the efficacy of genetic therapies.

Collaborations

One of her notable collaborators is C Anthony Hunt, with whom she has worked on various projects related to her patent.

Conclusion

Sarah B Noonberg's contributions to biotechnology through her innovative patent demonstrate her dedication to advancing the field. Her work has the potential to lead to significant advancements in therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…